Back to Journals » Therapeutics and Clinical Risk Management » Volume 7

Therapeutics and Clinical Risk Management


Archive: Volume 7, 2011

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

Gori B, Ricciardi S, Fulvi A, Intagliata S, Del Signore E, de Marinis F

Therapeutics and Clinical Risk Management 2011, 7:429-440

Published Date: 17 November 2011

Role of iron supplementation in promoting maternal and fetal outcome

Yekta Z, Pourali R, Mladkova N, Ghasemi-rad M , Boromand F, Hazrati Tappeh K

Therapeutics and Clinical Risk Management 2011, 7:421-428

Published Date: 31 October 2011

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

Casanova M, Medina-Pérez A, Moreno-Beltran M, Mata-Vazquez M, Rueda A

Therapeutics and Clinical Risk Management 2011, 7:401-408

Published Date: 7 October 2011

Cancer patient-centered home care: a new model for health care in oncology

Tralongo P, Ferraù F, Borsellino N, Verderame F, Caruso M, Giuffrida D, Butera A, Gebbia V

Therapeutics and Clinical Risk Management 2011, 7:387-392

Published Date: 9 September 2011

The effect of a physician-targeted intervention on metoclopramide prescribing practice

Yang YX, Leonard CE, Freeman C, Hennessy S

Therapeutics and Clinical Risk Management 2011, 7:359-365

Published Date: 22 August 2011

Profile of ciclesonide for the maintenance treatment of asthma

Singas E, Karpel JP

Therapeutics and Clinical Risk Management 2011, 7:351-358

Published Date: 19 August 2011

Serum sodium disorders in patients with traumatic brain injury

Paiva WS, Bezerra DA, Amorim RL, Figueiredo EG, Tavares WM, De Andrade AF, Teixeira MJ

Therapeutics and Clinical Risk Management 2011, 7:345-349

Published Date: 11 August 2011

Effect of age on semen parameters in infertile men after varicocelectomy

Hassanzadeh-Nokashty K, Yavarikia P, Ghaffari A, Hazhir S, Hassanzadeh M

Therapeutics and Clinical Risk Management 2011, 7:333-336

Published Date: 9 August 2011

Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution

Mösges R, Nematian-Samani M, Eichel A

Therapeutics and Clinical Risk Management 2011, 7:325-326

Published Date: 27 July 2011

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N

Therapeutics and Clinical Risk Management 2011, 7:301-311

Published Date: 26 July 2011

Seven years’ experience with etidronate in a woman with anorexia nervosa and vertebral fractures

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto H

Therapeutics and Clinical Risk Management 2011, 7:275-281

Published Date: 5 July 2011

Conestat alfa for the treatment of angioedema attacks

Davis B, Bernstein JA

Therapeutics and Clinical Risk Management 2011, 7:265-273

Published Date: 1 July 2011

Clinical potential of lurasidone in the management of schizophrenia

Samalin L, Garnier M, Llorca PM

Therapeutics and Clinical Risk Management 2011, 7:239-250

Published Date: 27 June 2011

New form of administering chlorhexidine for treatment of denture-induced stomatitis

Ryalat S, Darwish R, Amin W

Therapeutics and Clinical Risk Management 2011, 7:219-225

Published Date: 14 June 2011

Quantifying the impact of nonadherence patterns on exposure to oral immunosuppressants

Maclean JR, Pfister M, Zhou Z, Roy A, Tuomari VA, Heifets M

Therapeutics and Clinical Risk Management 2011, 7:149-156

Published Date: 11 April 2011

Gynecomastia – evaluation and current treatment options

Murad MH, Johnson RE, Kermott CA

Therapeutics and Clinical Risk Management 2011, 7:145-148

Published Date: 28 March 2011

Atrial fibrillation and the use of oral bisphosphonates

Michael Pazianas, Cyrus Cooper, Yiting Wang, et al

Therapeutics and Clinical Risk Management 2011, 7:131-144

Published Date: 22 March 2011

Management of Huntington’s disease: role of tetrabenazine

Marina de Tommaso, Claudia Serpino, Vittorio Sciruicchio

Therapeutics and Clinical Risk Management 2011, 7:123-129

Published Date: 21 March 2011

Broadening the use of antiretroviral therapy: the case for feline leukemia virus

Willie M Greggs III, Christine L Clouser, Steven E Patterson, et al

Therapeutics and Clinical Risk Management 2011, 7:115-122

Published Date: 16 March 2011

Inferior vena cava filters in cancer patients: to filter or not to filter

Hikmat Abdel-Razeq, Asem Mansour, Yousef Ismael, et al

Therapeutics and Clinical Risk Management 2011, 7:99-102

Published Date: 10 March 2011

A causative link between periodontal disease and glomerulonephritis: a preliminary study

Mohammad Reza Ardalan, Kamyar Ghabili, Reza Pourabbas, et al

Therapeutics and Clinical Risk Management 2011, 7:93-98

Published Date: 8 March 2011

Pharmacological and clinical overview of cloperastine in treatment of cough

Maria Antonietta Catania, Salvatore Cuzzocrea

Therapeutics and Clinical Risk Management 2011, 7:83-92

Published Date: 7 March 2011

Enzyme replacement therapy for Fabry disease: some answers but more questions

Majid Alfadhel, Sandra Sirrs

Therapeutics and Clinical Risk Management 2011, 7:69-82

Published Date: 25 February 2011

A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk

Daniele Franchi, Davide Cini, Giorgio Iervasi

Therapeutics and Clinical Risk Management 2011, 7:59-68

Published Date: 17 February 2011

Anorexia nervosa versus hyperinsulinism: therapeutic effects of neuropharmacological manipulation

Fuad Lechin, Bertha van der Dijs, Betty Pardey-Maldonado, et al

Therapeutics and Clinical Risk Management 2011, 7:53-58

Published Date: 17 February 2011

Genitourinary system trauma after 2003 Bam earthquake in Kerman, Iran

Mohammad Hasan Dehghani Firoozabadi, Mehdi Abedinzadeh, Mohammad Kazem Moslemi

Therapeutics and Clinical Risk Management 2011, 7:49-52

Published Date: 9 February 2011

Pirfenidone treatment of idiopathic pulmonary fibrosis

Ye Gan, Erica L Herzog, Richard H Gomer

Therapeutics and Clinical Risk Management 2011, 7:39-47

Published Date: 8 February 2011

Paroxysmal atrial fibrillation in cryptogenic stroke

Neha S Dangayach, Kevin Kane, Majaz Moonis

Therapeutics and Clinical Risk Management 2011, 7:33-37

Published Date: 28 January 2011

The lupus band test in systemic lupus erythematosus patients

Adam Reich, Katarzyna Marcinow, Rafal Bialynicki-Birula

Therapeutics and Clinical Risk Management 2011, 7:27-32

Published Date: 24 January 2011

Investigation of pulmonary infection pathogens in neurological intensive care unit

Fengying Quan, Guangwei Liu, Liang Wang, et al

Therapeutics and Clinical Risk Management 2011, 7:21-25

Published Date: 21 January 2011

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures

Maria Adriana Cataldo, Nicola Petrosillo

Therapeutics and Clinical Risk Management 2011, 7:13-20

Published Date: 13 January 2011

Role of rituximab in first-line treatment of chronic lymphocytic leukemia

Jeffrey Bryan, Gautam Borthakur

Therapeutics and Clinical Risk Management 2011, 7:1-11

Published Date: 22 December 2010